EPIX Annual CFF
$925.50 K
+$993.70 K+1457.04%
30 September 2024
Summary:
As of January 23, 2025, EPIX annual cash flow from financing activities is $925.50 thousand, with the most recent change of +$993.70 thousand (+1457.04%) on September 30, 2024. During the last 3 years, it has fallen by -$141.07 million (-99.35%). EPIX annual CFF is now -99.35% below its all-time high of $141.99 million, reached on September 30, 2021.EPIX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPIX Quarterly CFF
$59.70 K
+$34.10 K+133.20%
30 September 2024
Summary:
As of January 23, 2025, EPIX quarterly cash flow from financing activities is $59.70 thousand, with the most recent change of +$34.10 thousand (+133.20%) on September 30, 2024. Over the past year, it has increased by +$34.10 thousand (+133.20%). EPIX quarterly CFF is now -99.96% below its all-time high of $141.64 million, reached on March 31, 2021.EPIX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPIX TTM CFF
$925.60 K
+$73.30 K+8.60%
30 September 2024
Summary:
As of January 23, 2025, EPIX TTM cash flow from financing activities is $925.60 thousand, with the most recent change of +$73.30 thousand (+8.60%) on September 30, 2024. Over the past year, it has increased by +$73.30 thousand (+8.60%). EPIX TTM CFF is now -99.51% below its all-time high of $187.75 million, reached on June 30, 2021.EPIX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPIX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1457.0% | +133.2% | +8.6% |
| 3 y3 years | -99.3% | +348.9% | -99.3% |
| 5 y5 years | -98.2% | -99.9% | -98.0% |
EPIX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.3% | +1457.0% | -90.7% | +268.2% | -99.3% | +1140.0% |
| 5 y | 5-year | -99.3% | +1457.0% | -100.0% | +101.5% | -99.5% | +1140.0% |
| alltime | all time | -99.3% | +1457.0% | -100.0% | +101.5% | -99.5% | +124.1% |
ESSA Pharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | $925.50 K(-1457.0%) | $59.70 K(+133.2%) | $925.60 K(+8.6%) |
| June 2024 | - | $25.60 K(-96.0%) | $852.30 K(+7.7%) |
| Mar 2024 | - | $643.60 K(+227.2%) | $791.20 K(+600.2%) |
| Dec 2023 | - | $196.70 K(-1546.3%) | $113.00 K(-266.2%) |
| Sept 2023 | -$68.20 K(-127.0%) | -$13.60 K(-61.7%) | -$68.00 K(-23.6%) |
| June 2023 | - | -$35.50 K(+2.6%) | -$89.00 K(+83.1%) |
| Mar 2023 | - | -$34.60 K(-320.4%) | -$48.60 K(-128.7%) |
| Dec 2022 | - | $15.70 K(-145.4%) | $169.10 K(-33.1%) |
| Sept 2022 | $252.70 K(-99.8%) | -$34.60 K(-806.1%) | $252.70 K(-15.9%) |
| June 2022 | - | $4900.00(-97.3%) | $300.60 K(-38.0%) |
| Mar 2022 | - | $183.10 K(+84.4%) | $484.90 K(-99.7%) |
| Dec 2021 | - | $99.30 K(+646.6%) | $141.94 M(-0.0%) |
| Sept 2021 | $141.99 M(+239.9%) | $13.30 K(-93.0%) | $141.99 M(-24.4%) |
| June 2021 | - | $189.20 K(-99.9%) | $187.75 M(+0.1%) |
| Mar 2021 | - | $141.64 M(>+9900.0%) | $187.61 M(+308.2%) |
| Dec 2020 | - | $150.90 K(-99.7%) | $45.96 M(+10.0%) |
| Sept 2020 | $41.78 M(-17.4%) | $45.77 M(>+9900.0%) | $41.78 M(-15.8%) |
| June 2020 | - | $51.30 K(-645.7%) | $49.61 M(+3.1%) |
| Mar 2020 | - | -$9400.00(-99.8%) | $48.12 M(+1.7%) |
| Dec 2019 | - | -$4.04 M(-107.5%) | $47.33 M(-6.4%) |
| Sept 2019 | $50.56 M | $53.60 M(-3839.8%) | $50.56 M(-1416.3%) |
| June 2019 | - | -$1.43 M(+78.6%) | -$3.84 M(+19.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$802.70 K(0.0%) | -$3.21 M(-115.5%) |
| Dec 2018 | - | -$802.70 K(0.0%) | $20.65 M(-3.1%) |
| Sept 2018 | $21.31 M(+72.9%) | -$802.70 K(+0.7%) | $21.31 M(-2.0%) |
| June 2018 | - | -$797.40 K(-103.5%) | $21.75 M(-2.7%) |
| Mar 2018 | - | $23.06 M(<-9900.0%) | $22.35 M(+413.8%) |
| Dec 2017 | - | -$146.60 K(-59.1%) | $4.35 M(-64.7%) |
| Sept 2017 | $12.33 M(-45.8%) | -$358.60 K(+76.4%) | $12.33 M(-2.8%) |
| June 2017 | - | -$203.30 K(-104.0%) | $12.69 M(+0.1%) |
| Mar 2017 | - | $5.06 M(-35.4%) | $12.67 M(-52.7%) |
| Dec 2016 | - | $7.83 M(>+9900.0%) | $26.81 M(+17.9%) |
| Sept 2016 | $22.74 M(+80.6%) | $0.00(-100.0%) | $22.74 M(-0.0%) |
| June 2016 | - | -$217.10 K(-101.1%) | $22.75 M(-1.5%) |
| Mar 2016 | - | $19.19 M(+409.4%) | $23.09 M(+61.8%) |
| Dec 2015 | - | $3.77 M(>+9900.0%) | $14.28 M(+13.4%) |
| Sept 2015 | $12.59 M(+122.5%) | $10.90 K(-90.9%) | $12.59 M(-27.3%) |
| June 2015 | - | $119.70 K(-98.8%) | $17.32 M(-4.4%) |
| Mar 2015 | - | $10.38 M(+398.0%) | $18.12 M(+134.0%) |
| Dec 2014 | - | $2.08 M(-56.1%) | $7.74 M(+36.8%) |
| Sept 2014 | $5.66 M | $4.74 M(+418.3%) | $5.66 M(+518.3%) |
| June 2014 | - | $915.20 K(>+9900.0%) | $915.20 K(>+9900.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | - | $0.00 | $0.00 |
FAQ
- What is ESSA Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for ESSA Pharma?
- What is ESSA Pharma annual CFF year-on-year change?
- What is ESSA Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ESSA Pharma?
- What is ESSA Pharma quarterly CFF year-on-year change?
- What is ESSA Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for ESSA Pharma?
- What is ESSA Pharma TTM CFF year-on-year change?
What is ESSA Pharma annual cash flow from financing activities?
The current annual CFF of EPIX is $925.50 K
What is the all time high annual CFF for ESSA Pharma?
ESSA Pharma all-time high annual cash flow from financing activities is $141.99 M
What is ESSA Pharma annual CFF year-on-year change?
Over the past year, EPIX annual cash flow from financing activities has changed by +$993.70 K (+1457.04%)
What is ESSA Pharma quarterly cash flow from financing activities?
The current quarterly CFF of EPIX is $59.70 K
What is the all time high quarterly CFF for ESSA Pharma?
ESSA Pharma all-time high quarterly cash flow from financing activities is $141.64 M
What is ESSA Pharma quarterly CFF year-on-year change?
Over the past year, EPIX quarterly cash flow from financing activities has changed by +$34.10 K (+133.20%)
What is ESSA Pharma TTM cash flow from financing activities?
The current TTM CFF of EPIX is $925.60 K
What is the all time high TTM CFF for ESSA Pharma?
ESSA Pharma all-time high TTM cash flow from financing activities is $187.75 M
What is ESSA Pharma TTM CFF year-on-year change?
Over the past year, EPIX TTM cash flow from financing activities has changed by +$73.30 K (+8.60%)